Entering 2015, ABILIFY was the #1 selling drug in the U.S. But with generics on the horizon, ABILIFY’s market share was likely to plummet. If cost were no issue, many ABILIFY patients would prefer to stick with the brand they know. We cemented that brand loyalty with the bold, conceptual, savings-focused “Save With Abe” campaign.
